Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Frontiers in Immunology|May 15, 2026
Case Report: Evolution of a BRAF V600E-mutant papillary thyroid carcinoma from latissimus dorsi metastasis and squamous transformation to PD-L1 upregulation and effective immunotherapyDan Tian, Shuqin Deng, Gaowa Jin, et al.International Journal of Biological Macromolecules|November 8, 2021
SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfateYi Zheng, Jinxiang Zhao, Jiaqi Li, et al.Open Medicine (Warsaw, Poland)|March 27, 2018
Evaluation of a Neurokinin-1 Antagonist in Preventing Multiple-day Cisplatin-induced Nausea and VomitingQuanfu Li, Wenjuan Wang, Gang Chen, et al.Current Problems in Cancer|February 3, 2019
Effectiveness and safety of combined neurokinin-1 antagonist aprepitant treatment for multiple-day anthracycline-induced nausea and vomitingQuanfu Li, Yungaowa Wu, Wenjuan Wang, et al.Talanta|May 23, 2018
On-line comprehensive two-dimensional liquid chromatography tandem mass spectrometry for the analysis of Curcuma kwangsiensisWeijia Zhou, Zhimou Guo, Long Yu, et al.Pharmacogenomics and Personalized Medicine|July 22, 2021
Clinical Observation of Gene Polymorphism of Olanzapine or Aprepitant in Prevention of CINVYilan Jin, Gaowa Jin, Jun Zhao, et al.International Journal of Clinical Practice|September 21, 2022
A Comparison of the Efficacy of 5 mg Olanzapine and Aprepitant in the Prevention of Multiple-Day Cisplatin Chemotherapy-Induced Nausea and VomitingGuang Liu, Yilan Jin, Ying Jiang, et al.Nutrition and Cancer|December 19, 2022
Association between Body Composition and Peripheral Neurotoxicity in Cancer Patients from North China Taking Nab-PaclitaxelJiayuan Guo, Juan Zhao, Ming Gu, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 22, 2022
Olanzapine (5 mg) plus standard triple antiemetic therapy for the prevention of multiple-day cisplatin hemotherapy-induced nausea and vomiting: a prospective randomized controlled studyJiali Gao, Jun Zhao, Caihong Jiang, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 26, 2024
Kukoamine A alleviates nephrolithiasis by inhibiting endogenous oxalate synthesis via the IL-6/JAK/STAT3/DAO signaling pathwayYingjie Ju, Mengwei Du, Zhongyi Wang, et al.Pageof 7